Character Biosciences
Character Biosciences, Inc.
Character Biosciences, Inc. is a precision medicine company dedicated to developing targeted therapies that address complex progressive polygenic diseases, particularly age-related eye conditions like age-related macular degeneration (AMD) and primary open-angle glaucoma (POAG). The company utilizes advanced genetic and clinical data integration to foster innovative solutions in ophthalmology.
Products & Team
Integrated Patient Data Platform and AI Engine
This platform aggregates and analyzes detailed patient data, including genetic and clinical outcome information, enabling the identification of new drug targets for AMD and POAG. It aims to facilitate the creation of targeted therapies that address the genetic underpinnings of these diseases.
The platform solves the need for effective treatments in progressive vision-loss diseases by enabling more precise and effective therapeutic development.
The lack of effective treatments for advanced forms of progressive eye diseases and the need for personalized medicine based on genetic profiles.